Morgan Stanley Reiterates Overweight on MetLife, Maintains $78 Price Target
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Nigel Dally has reiterated an Overweight rating on MetLife (NYSE:MET) and maintained a $78 price target.
August 04, 2023 | 1:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has reiterated an Overweight rating on MetLife and maintained a $78 price target.
The reiteration of an Overweight rating by Morgan Stanley indicates a positive outlook for MetLife. The maintained price target of $78 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100